Literature DB >> 24480557

Opium use: an emerging risk factor for cancer?

Farin Kamangar1, Ramin Shakeri2, Reza Malekzadeh2, Farhad Islami3.   

Abstract

An estimated 16·5 million people worldwide illicitly use opiates, of whom 4 million use raw opium. We did a systematic review to investigate the association between opium use and cancer incidence and mortality. Opium use was associated with an increased risk of cancers of the oesophagus, stomach, larynx, lung, and urinary bladder. Although the present evidence suggests that these associations are possibly causal, further epidemiological studies (particularly prospective studies that collect detailed data about lifetime opium use and control for a broad range of potential confounders) are needed.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24480557     DOI: 10.1016/S1470-2045(13)70550-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  30 in total

Review 1.  International cancer seminars: a focus on esophageal squamous cell carcinoma.

Authors:  G Murphy; V McCormack; B Abedi-Ardekani; M Arnold; M C Camargo; N A Dar; S M Dawsey; A Etemadi; R C Fitzgerald; D E Fleischer; N D Freedman; A M Goldstein; S Gopal; M Hashemian; N Hu; P L Hyland; B Kaimila; F Kamangar; R Malekzadeh; C G Mathew; D Menya; G Mulima; M M Mwachiro; A Mwasamwaja; N Pritchett; Y-L Qiao; L F Ribeiro-Pinto; M Ricciardone; J Schüz; F Sitas; P R Taylor; K Van Loon; S-M Wang; W-Q Wei; C P Wild; C Wu; C C Abnet; S J Chanock; P Brennan
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976

Review 2.  Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.

Authors:  Parisa Karimi; Farhad Islami; Sharmila Anandasabapathy; Neal D Freedman; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-11       Impact factor: 4.254

3.  Opiate and Tobacco Use and Exposure to Carcinogens and Toxicants in the Golestan Cohort Study.

Authors:  Arash Etemadi; Hossein Poustchi; Antonia M Calafat; Benjamin C Blount; Victor R De Jesús; Lanqing Wang; Akram Pourshams; Ramin Shakeri; Maki Inoue-Choi; Meredith S Shiels; Gholamreza Roshandel; Gwen Murphy; Connie S Sosnoff; Deepak Bhandari; Jun Feng; Baoyun Xia; Yuesong Wang; Lei Meng; Farin Kamangar; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh; Neal D Freedman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-01-08       Impact factor: 4.254

4.  Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study.

Authors:  Shirin Moossavi; Mehdi Mohamadnejad; Akram Pourshams; Hossein Poustchi; Farhad Islami; Maryam Sharafkhah; Babak Mirminachi; Siavosh Nasseri-Moghaddam; Shahryar Semnani; Ramin Shakeri; Arash Etemadi; Shahin Merat; Masoud Khoshnia; Sanford M Dawsey; Paul D Pharoah; Paul Brennan; Christian C Abnet; Paolo Boffetta; Farin Kamangar; Reza Malekzadeh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-12-20       Impact factor: 4.254

5.  Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression.

Authors:  Muhammad R Haque; Usman Barlass; Andrew Armstrong; Maliha Shaikh; Faraz Bishehsari
Journal:  Mol Cell Biochem       Date:  2022-02-09       Impact factor: 3.396

Review 6.  Opium Use and Cancer Risk: A Comprehensive Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Masoume Mansouri; Sina Naghshi; Mahbobeh Parsaeian; Sadaf G Sepanlou; Hossein Poustchi; Zahra Momayez Sanat; Omid Sadeghi; Akram Pourshams
Journal:  Int J Clin Pract       Date:  2022-02-18       Impact factor: 3.149

7.  Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran.

Authors:  Maryam Hadji; Hamideh Rashidian; Maryam Marzban; Ahmad Naghibzadeh-Tahami; Mahin Gholipour; Elham Mohebbi; Roya Safari-Faramani; Monireh Sadat Seyyedsalehi; Bayan Hosseini; Mahdieh Bakhshi; Reza Alizadeh-Navaei; Lida Ahmadi; Abbas Rezaianzadeh; Abdolvahab Moradi; Alireza Ansari-Moghaddam; Azim Nejatizadeh; Soodabeh ShahidSales; Farshad Zohrabi; Reza Mohammadi; Mohammad Reza Nowroozi; Hossein Poustchi; Dariush Nasrollahzadeh; Farid Najafi; Ali Akbar Haghdoost; Afarin Rahimi-Movaghar; Arash Etemadi; Mohammad Ali Mohagheghi; Reza Malekzadeh; Paul Brennan; Joachim Schüz; Paolo Boffetta; Elisabete Weiderpass; Farin Kamangar; Kazem Zendehdel; Eero Pukkala
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

8.  Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study.

Authors:  Mahdi Nalini; Masoud Khoshnia; Farin Kamangar; Maryam Sharafkhah; Hossein Poustchi; Akram Pourshams; Gholamreza Roshandel; Samad Gharavi; Mahdi Zahedi; Alireza Norouzi; Masoud Sotoudeh; Arash Nikmanesh; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh; Arash Etemadi
Journal:  Int J Epidemiol       Date:  2021-03-03       Impact factor: 7.196

9.  Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From the Golestan Cohort Study.

Authors:  Mahdi Sheikh; Hossein Poustchi; Akram Pourshams; Arash Etemadi; Farhad Islami; Masoud Khoshnia; Abdolsamad Gharavi; Maryam Hashemian; Gholamreza Roshandel; Hooman Khademi; Mahdi Zahedi; Behnoush Abedi-Ardekani; Paolo Boffetta; Farin Kamangar; Sanford M Dawsey; Paul D Pharaoh; Christian C Abnet; Nicholas E Day; Paul Brennan; Reza Malekzadeh
Journal:  Gastroenterology       Date:  2019-01-03       Impact factor: 22.682

10.  Mortality from respiratory diseases associated with opium use: a population-based cohort study.

Authors:  Atieh Rahmati; Ramin Shakeri; Hooman Khademi; Hossein Poutschi; Akram Pourshams; Arash Etemadi; Masoud Khoshnia; Amir Ali Sohrabpour; Ali Aliasgari; Elham Jafari; Farhad Islami; Shahryar Semnani; Abdolsamad Gharravi; Christian C Abnet; Paul D P Pharoah; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Reza Malekzadeh; Farin Kamangar
Journal:  Thorax       Date:  2016-11-24       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.